DocPharma, a healthcare supply chain startup, has raised $2 million (approximately ₹19 crore) in a Pre-Series A funding round led by Equentis. Existing investor 100Unicorns, angel network Vinners, and several strategic angel investors also participated in the round. The capital will support the company's expansion into 50 cities across India and the establishment of 100 new licensed dark stores.
Funding and Expansion Plans
The new funding will be deployed primarily to scale DocPharma's physical fulfillment infrastructure and expand its presence beyond current operating regions. The startup currently operates across more than 12 cities and plans to reach over 50 cities, adding 100 new licensed dark stores in the process. The investment is expected to strengthen the company's ability to meet rising demand from healthcare platforms and partner businesses.
Platform and Technology Capabilities
DocPharma operates as a backend supply chain provider rather than a consumer-facing e-pharmacy, serving healthcare platforms that do not need to build their own logistics. Its proprietary system, DocPharma One, integrates warehouse management, inventory intelligence, order management, and fulfillment operations into a single interface. Each dark store carries more than 40,000 SKUs and is supported by an artificial intelligence-driven, pharmacist-led compliance infrastructure that helps meet prescription requirements.
Founding Team and Operational Approach
DocPharma was founded in 2024 by Saquib Ali, Shashank Rai, and Sagar Chauhan to address fragmentation in healthcare fulfillment. The founders have prioritized building licensed infrastructure one dark store at a time, focusing on compliance and reliability as the company scales. According to co-founder Shashank Rai, this disciplined approach is intended to ensure the supply chain remains robust as the startup enters 50 cities.
Strategic Role of Licensed Dark Stores
DocPharma's dark stores are designed to operate as regulated fulfillment points that combine physical inventory with digital oversight. They enable pharmacies, hospitals, health insurers, direct-to-consumer wellness and nutraceutical brands, and pet care businesses to fulfill healthcare orders quickly. The startup says its licensed infrastructure removes the need for partners to build and operate their own supply chains, reducing time and capital requirements.
Partner Network and Compliance Focus
The startup currently works behind the scenes for more than 30 healthcare and wellness platforms, including e-pharmacies, hospitals, health insurers, corporate wellness programs, and direct-to-consumer brands. This infrastructure enables partner platforms to offer delivery of medicines and healthcare products in under 30 minutes. DocPharma has fulfilled more than 800,000 orders to date while maintaining a fulfillment rate above 95 percent.
Investor and Market Context
Manish Goel, founder-director of Equentis, said healthcare is one of India's fastest-growing sectors but its supply chain has remained fragmented. He added that DocPharma has built a platform combining licensed infrastructure, AI-powered technology, and operational expertise into a scalable healthcare supply chain. This investor confidence reflects wider interest in vertical quick commerce models that focus on specialized delivery categories.
Growth of Quick Commerce in Healthcare
The fundraising comes at a time when rapid medicine delivery is gaining momentum in India. Similar companies have attracted funding, including Plazza, which raised $15 million in a Series A round to strengthen its technology platform and AI-led inventory capabilities. DocPharma's latest round positions it to capture growing demand for compliant and fast healthcare order fulfillment across more cities.
The Pre-Series A round marks a significant step in DocPharma's infrastructure-led approach to healthcare logistics. By expanding its dark store network and strengthening its technology, the company aims to support a growing partner ecosystem without requiring platforms to build their own supply chains. The investment signals continued confidence in healthcare quick commerce as demand for fast, reliable, and compliant delivery continues to rise.